Triflupromazine

From WikiMD's WELLNESSPEDIA

Triflupromazine is a typical antipsychotic medication belonging to the phenothiazine class. It is primarily used in the treatment of schizophrenia and other psychotic disorders. Triflupromazine is known for its sedative properties and is sometimes used to manage severe nausea and vomiting.

Chemical Structure[edit]

Triflupromazine is a derivative of phenothiazine, characterized by the presence of a trifluoromethyl group. Its chemical formula is C18H19F3N2S, and it has a molecular weight of 352.42 g/mol. The structure of triflupromazine can be visualized in the following images:

Chemical structure of Triflupromazine
3D model of Triflupromazine

Pharmacology[edit]

Triflupromazine works by blocking dopamine receptors in the brain, which helps to reduce symptoms of psychosis. It also has antihistaminic and anticholinergic properties, contributing to its sedative effects. The medication is metabolized in the liver and excreted primarily in the urine.

Medical Uses[edit]

Triflupromazine is used to treat a variety of psychiatric conditions, including:

It is also used as an antiemetic to control severe nausea and vomiting, particularly in patients undergoing chemotherapy.

Side Effects[edit]

Common side effects of triflupromazine include:

Serious side effects may include:

History[edit]

Triflupromazine was first introduced in the 1950s as one of the early antipsychotic medications. It was developed as part of the phenothiazine class, which includes other well-known antipsychotics such as chlorpromazine.

Related Pages[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.